InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by HOFFMAN STEPHEN J, Director. Officer active across 3 companies, notably Dicerna Pharmaceuticals Inc. In total, 10 reports have been published. Activity tracked since 17 June 2021. The latest transaction was disclosed on 24 June 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
10 of 10 declarations
Stephen J. Hoffman is a Board Member at Dicerna Pharmaceuticals Inc and AcelRx Pharmaceuticals Inc. He brings his expertise in governance and strategy, actively participating in the direction of both companies.